Display options
Cite
Jacob A, Zhou M, Wu R, et al. The role of hepatic cytochrome P-450 in sepsis. Int J Clin Exp Med. 2009;2(3):203-11
Jacob, A., Zhou, M., Wu, R., & Wang, P. (2009). The role of hepatic cytochrome P-450 in sepsis. International journal of clinical and experimental medicine, 2(3), 203-11.
Jacob, Asha, et al. "The role of hepatic cytochrome P-450 in sepsis." International journal of clinical and experimental medicine vol. 2,3 (2009): 203-11.
Jacob A, Zhou M, Wu R, Wang P. The role of hepatic cytochrome P-450 in sepsis. Int J Clin Exp Med. 2009 Aug 25;2(3):203-11. PMID: 19918313; PMCID: PMC2770183.
Copy Download .nbib Format: NLM
Share it on

Int J Clin Exp Med. 2009 Aug 25;2(3):203-11.

The role of hepatic cytochrome P-450 in sepsis.

International journal of clinical and experimental medicine

Asha Jacob, Mian Zhou, Rongqian Wu, Ping Wang

Affiliations

  1. Department of Surgery, North Shore University Hospital-Long Island Jewish Medical Center & Feinstein Institute for Medical Research, 350 Community Drive Manhasset, NY 11030.

PMID: 19918313 PMCID: PMC2770183

Abstract

Severe sepsis is a common, expensive, and fatal condition with as many deaths annually as those from acute myocardial infarctions. The average cost per case seems to exceed $22,000. The increased morbidity and mortality attributed to sepsis could be due to the lack of our understanding of mediators and factors responsible for early cellular alterations and thus could not be intervened which result in progressive deterioration of cell and organ function and even death. It has been well documented that hepatocellular dysfunction occurs early in sepsis and it contributes to multiple organ failure and ultimately death; however the exact mechanism is poorly understood. We and others have shown that cytochrome P-450 (CYP) enzyme system, a superfamily of heme proteins responsible for the metabolism of a variety of endogenous and exogenous substances, plays a crucial role in the prevention of hepatocellular dysfunction in sepsis. In this review, we describe the alterations of CYP enzymes in the experimental model of sepsis and provide the limited information available in septic and severely injured patients. We also review the potential mechanism for the alterations of CYP enzymes in sepsis. Finally, we highlight the importance of future studies needed to understand the regulation of CYP isoforms to develop therapy for hepatocellular dysfunction in sepsis.

Keywords: CYP enzymes; Cytochrome P-450; hepatic dysfunction; liver; sepsis

References

  1. Arch Biochem Biophys. 1999 Sep 1;369(1):1-10 - PubMed
  2. Drug Metab Dispos. 2001 Mar;29(3):207-12 - PubMed
  3. Pharmacol Toxicol. 2000 Feb;86(2):71-7 - PubMed
  4. Ann N Y Acad Sci. 1996 Dec 27;804:266-75 - PubMed
  5. Am J Physiol. 1992 Jul;263(1 Pt 1):G38-43 - PubMed
  6. Curr Drug Metab. 2001 Jun;2(2):165-83 - PubMed
  7. J Pharmacol Exp Ther. 1997 Dec;283(3):1479-85 - PubMed
  8. Arch Biochem Biophys. 1999 Sep 1;369(1):11-23 - PubMed
  9. Shock. 2000;13(4):325-9 - PubMed
  10. Curr Top Med Chem. 2003;3(14):1573-99 - PubMed
  11. N Engl J Med. 2003 Jul 31;349(5):474-85 - PubMed
  12. Cell. 1995 Dec 15;83(6):851-7 - PubMed
  13. Am J Physiol. 1996 May;270(5 Pt 2):R927-38 - PubMed
  14. Crit Care Med. 2002 Dec;30(12):2729-35 - PubMed
  15. Drug Metab Rev. 1997 Feb-May;29(1-2):413-580 - PubMed
  16. Crit Care Med. 2001 Mar;29(3):473-81 - PubMed
  17. Crit Care Med. 2001 Jul;29(7):1303-10 - PubMed
  18. Surgery. 2001 Aug;130(2):339-45 - PubMed
  19. Biochem Pharmacol. 1996 Oct 25;52(8):1195-200 - PubMed
  20. Arch Biochem Biophys. 1995 Jul 10;320(2):380-9 - PubMed
  21. Structure. 1998 Sep 15;6(9):1079-85 - PubMed
  22. J Leukoc Biol. 1989 Sep;46(3):254-62 - PubMed
  23. Biochem J. 2000 Apr 15;347(Pt 2):321-37 - PubMed
  24. Arch Biochem Biophys. 2000 Dec 1;384(1):190-8 - PubMed
  25. Annu Rev Pharmacol Toxicol. 1995;35:307-40 - PubMed
  26. Clin Pharmacokinet. 1999 Dec;37(6):485-505 - PubMed
  27. Am J Physiol. 1993 Jul;265(1 Pt 1):G126-32 - PubMed
  28. Ann Surg. 1991 Aug;214(2):141-8 - PubMed
  29. Semin Liver Dis. 1983 Nov;3(4):318-29 - PubMed
  30. Pharmacogenetics. 1996 Feb;6(1):1-42 - PubMed
  31. Cell. 1995 Dec 15;83(6):835-9 - PubMed
  32. Mol Cell Biol. 1996 Oct;16(10):5221-31 - PubMed
  33. N Engl J Med. 2001 Mar 8;344(10):699-709 - PubMed
  34. Mol Pharmacol. 1996 May;49(5):796-801 - PubMed
  35. Nat Med. 2003 May;9(5):517-24 - PubMed
  36. Int J Mol Med. 2006 Aug;18(2):339-46 - PubMed
  37. N Engl J Med. 2003 Jan 9;348(2):138-50 - PubMed
  38. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4437-41 - PubMed
  39. Mol Pharmacol. 1993 Oct;44(4):707-15 - PubMed
  40. Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):296-301 - PubMed
  41. Res Commun Mol Pathol Pharmacol. 1998 Oct;102(1):57-68 - PubMed
  42. Clin Pharmacol Ther. 2004 Jan;75(1):80-8 - PubMed
  43. Eur J Pharmacol. 1999 Feb 26;368(1):75-87 - PubMed
  44. N Engl J Med. 2001 Nov 8;345(19):1359-67 - PubMed
  45. Am J Pathol. 2002 Dec;161(6):2283-94 - PubMed
  46. J Endotoxin Res. 2002;8(6):473-6 - PubMed
  47. Eur J Pharmacol. 1995 Apr 24;277(2-3):123-32 - PubMed
  48. J Immunol. 2003 Dec 15;171(12):6827-37 - PubMed
  49. Arch Surg. 1997 Apr;132(4):364-9; discussion 369-70 - PubMed
  50. Crit Care Med. 2005 Mar;33(3):541-6 - PubMed
  51. J Clin Invest. 1994 Dec;94(6):2209-14 - PubMed
  52. Hepatology. 1995 Oct;22(4 Pt 1):1143-53 - PubMed
  53. Mol Endocrinol. 2000 Oct;14(10):1674-81 - PubMed
  54. Shock. 2002 Jan;17(1):55-60 - PubMed
  55. J Immunol. 2003 Jul 15;171(2):909-14 - PubMed
  56. Crit Care Med. 2004 Feb;32(2):502-8 - PubMed
  57. J Leukoc Biol. 2003 Sep;74(3):344-51 - PubMed
  58. Nature. 2002 Dec 19-26;420(6917):853-9 - PubMed
  59. Shock. 2002 Jun;17(6):463-7 - PubMed
  60. J Surg Res. 1980 Aug;29(2):189-201 - PubMed
  61. J Biol Chem. 1995 Oct 20;270(42):25291-300 - PubMed
  62. Mol Cell Biol. 1993 Apr;13(4):2504-14 - PubMed
  63. Shock. 2001 Jul;16(1):1-8 - PubMed
  64. Int J Mol Med. 2008 Apr;21(4):423-8 - PubMed
  65. Clin Pharmacokinet. 1997 May;32(5):368-81 - PubMed
  66. N Engl J Med. 2003 Apr 17;348(16):1546-54 - PubMed
  67. Clin Microbiol Rev. 2003 Jul;16(3):379-414 - PubMed
  68. Intensive Care Med. 2003 Jun;29(6):980-984 - PubMed
  69. Biochemistry. 1996 Sep 24;35(38):12221-7 - PubMed
  70. Drug Metab Rev. 1999 Feb;31(1):29-41 - PubMed
  71. Drug Metab Rev. 1997 Nov;29(4):1129-88 - PubMed
  72. Mol Pharmacol. 1989 Nov;36(5):699-707 - PubMed
  73. Pharmacol Rev. 2003 Dec;55(4):649-73 - PubMed
  74. Biochem Biophys Res Commun. 1990 May 16;168(3):1217-22 - PubMed
  75. FASEB J. 2001 Apr;15(6):879-92 - PubMed
  76. Shock. 1995 Jan;3(1):21-6 - PubMed
  77. Shock. 2005 Feb;23(2):144-9 - PubMed
  78. Arch Surg. 1991 Feb;126(2):219-24 - PubMed
  79. J Trauma. 1999 Oct;47(4):706-12 - PubMed
  80. Shock. 2001 Jul;16(1):33-9 - PubMed
  81. J Surg Res. 1999 May 15;83(2):151-7 - PubMed
  82. Shock. 2002 Mar;17(3):199-204 - PubMed
  83. J Surg Res. 1995 Dec;59(6):783-6 - PubMed
  84. Biochem Biophys Res Commun. 1992 Apr 30;184(2):960-5 - PubMed
  85. J Surg Res. 1990 Aug;49(2):186-96 - PubMed
  86. J Biol Chem. 1992 Apr 25;267(12):8050-5 - PubMed
  87. Shock. 2003 May;19(5):469-74 - PubMed
  88. Curr Med Chem. 2009;16(2):232-44 - PubMed
  89. Cell Mol Life Sci. 2001 May;58(5-6):737-47 - PubMed
  90. Nature. 2003 Jan 23;421(6921):384-8 - PubMed
  91. FASEB J. 1996 May;10(7):683-9 - PubMed
  92. Biochem Pharmacol. 2001 Dec 15;62(12):1709-17 - PubMed
  93. Shock. 1998 Jan;9(1):1-11 - PubMed
  94. Crit Care Med. 2002 Jan;30(1 Supp):S64-S73 - PubMed
  95. Arch Surg. 1999 Sep;134(9):922-9 - PubMed
  96. Am J Physiol Gastrointest Liver Physiol. 2003 Apr;284(4):G551-7 - PubMed
  97. Clin Pharmacokinet. 2002;41(14):1135-51 - PubMed
  98. J Vasc Res. 1995 Mar-Apr;32(2):79-92 - PubMed
  99. Science. 1992 May 22;256(5060):1193-5 - PubMed

Publication Types

Grant support